Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
diphtheria, tetanus, pertussis (acellular), and poliomyelitis (inactivated) vaccine
- Development stage
- Unknown
- Lead developer
- Boryung Biopharma
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Boryung DTaP-IPV Vaccine is a quadrivalent combination vaccine developed by Boryung Biopharma for the prevention of diphtheria, tetanus, pertussis, and poliomyelitis (polio). The vaccine combines antigens for diphtheria toxoid, tetanus toxoid, acellular pertussis (DTaP), and inactivated poliovirus (IPV) types 1, 2, and 3. By integrating these components into a single prefilled syringe, the vaccine reduces the number of injections required for infants and children during their primary immunization series. It is administered via intramuscular injection and is approved for use in South Korea.
- Brand names
- Boryung DTaP-IPV Vaccine
- Other names
- Boryung DTaP-IPV Vaccine Prefilled SyringeDTaP-IPV vaccine
02
Targets
Bordetella pertussis acellular antigenTT (Tetanus toxoid)
Beyond the preview
Go deeper on diphtheria, tetanus, pertussis (acellular), and poliomyelitis (inactivated) vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on diphtheria, tetanus, pertussis (acellular), and poliomyelitis (inactivated) vaccine.